CoImmune (formerly Argos Therapeutics) is an immunotherapy company developing treatments for cancer, autoimmune and inflammatory diseases. Its flagship program relies on the manufacturing of patient specific dendritic cells to treat their disease. Additionally, the company engages in contract manufacturing for cell-based therapies.